Biased agonism/antagonism at the AngII-AT1 receptor: Implications for adrenal aldosterone production and cardiovascular therapy
- PMID: 28511989
- DOI: 10.1016/j.phrs.2017.05.009
Biased agonism/antagonism at the AngII-AT1 receptor: Implications for adrenal aldosterone production and cardiovascular therapy
Abstract
Many of the effects of angiotensin II (AngII), including adrenocortical aldosterone release, are mediated by the AngII type 1 receptor (AT1R), a receptor with essential roles in cardiovascular homeostasis. AT1R belongs to the G protein-coupled receptor (GPCR) superfamily, mainly coupling to the Gq/11 type of G proteins. However, it also signals through βarrestins, oftentimes in parallel to eliciting G protein-dependent signaling. This has spurred infinite possibilities for cardiovascular pharmacology, since various beneficial effects are purportedly exerted by AT1R via βarrestins, unlike AT1R-induced G protein-mediated pathways that usually result in damaging cardiovascular effects, including hypertension and aldosterone elevation. Over the past decade however, a number of studies from our group and others have suggested that AT1R-induced βarrestin signaling can also be damaging for the heart, similarly to the G protein-dependent one, with regard to aldosterone regulation. Additionally, AT1R-induced βarrestin signaling in astrocytes from certain areas of the brain may also play a significant role in central regulation of blood pressure and hypertension pathogenesis. These findings have provided the impetus for testing available angiotensin receptor blockers (ARBs) in their efficacy towards blocking both routes (i.e. both G protein- and βarrestin-dependent) of AT1R signaling in vitro and in vivo and also have promoted structure-activity relationship (SAR) studies for the AngII molecule in terms of βarrestin signaling to certain cellular effects, e.g. adrenal aldosterone production. In the present review, we will recount all of these recent studies on adrenal and astrocyte AT1R-dependent βarrestin signaling while underlining their implications for cardiovascular pathophysiology and therapy.
Keywords: Adrenal gland; Aldosterone; Angiotensin type 1 receptor; Astrocyte; Heart disease; βArrestin-dependent signaling.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
Adrenal angiotensin II type 1 receptor biased signaling: The case for "biased" inverse agonism for effective aldosterone suppression.Cell Signal. 2021 Jun;82:109967. doi: 10.1016/j.cellsig.2021.109967. Epub 2021 Feb 25. Cell Signal. 2021. PMID: 33640432 Review.
-
Cardiovascular angiotensin II type 1 receptor biased signaling: Focus on non-Gq-, non-βarrestin-dependent signaling.Pharmacol Res. 2021 Dec;174:105943. doi: 10.1016/j.phrs.2021.105943. Epub 2021 Oct 15. Pharmacol Res. 2021. PMID: 34662735 Review.
-
Angiotensin II-dependent aldosterone production in the adrenal cortex.Vitam Horm. 2024;124:393-404. doi: 10.1016/bs.vh.2023.05.001. Epub 2023 Jun 1. Vitam Horm. 2024. PMID: 38408805
-
Angiotensin receptor blocker drugs and inhibition of adrenal beta-arrestin-1-dependent aldosterone production: Implications for heart failure therapy.World J Cardiol. 2017 Mar 26;9(3):200-206. doi: 10.4330/wjc.v9.i3.200. World J Cardiol. 2017. PMID: 28400916 Free PMC article.
-
Suppression of adrenal βarrestin1-dependent aldosterone production by ARBs: head-to-head comparison.Sci Rep. 2015 Jan 29;5:8116. doi: 10.1038/srep08116. Sci Rep. 2015. PMID: 25631300 Free PMC article.
Cited by
-
The place of ARBs in heart failure therapy: is aldosterone suppression the key?Ther Adv Cardiovasc Dis. 2019 Jan-Dec;13:1753944719868134. doi: 10.1177/1753944719868134. Ther Adv Cardiovasc Dis. 2019. PMID: 31401939 Free PMC article. Review.
-
Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID.Int J Mol Sci. 2021 Jul 31;22(15):8255. doi: 10.3390/ijms22158255. Int J Mol Sci. 2021. PMID: 34361021 Free PMC article. Review.
-
Higher plasma aldosterone concentrations in patients with aortic diseases and hypertension: a retrospective observational study.Eur J Med Res. 2023 Nov 26;28(1):541. doi: 10.1186/s40001-023-01528-2. Eur J Med Res. 2023. PMID: 38008731 Free PMC article.
-
Cross-Talk between Neurohormonal Pathways and the Immune System in Heart Failure: A Review of the Literature.Int J Mol Sci. 2019 Apr 5;20(7):1698. doi: 10.3390/ijms20071698. Int J Mol Sci. 2019. PMID: 30959745 Free PMC article. Review.
-
Microglia: The breakthrough to treat neovascularization and repair blood-retinal barrier in retinopathy.Front Mol Neurosci. 2023 Jan 23;16:1100254. doi: 10.3389/fnmol.2023.1100254. eCollection 2023. Front Mol Neurosci. 2023. PMID: 36756614 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous